相关实验视频

Updated: Jun 27, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

基于化聚乙烯胺的工程聚合物纳米颗粒使脏选择性mRNA输送成为可能

Hongqian Zhang¹, Dongshan Chen², Song Xue¹

¹Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China.

Molecular pharmaceutics

|December 18, 2025

概括

研究人员开发了新的聚合物纳米粒子 (PNPs),用于向的信使RNA (mRNA) 传递. 一个PNP变体选择性地将mRNA输送到脏,为mRNA治疗提供了一个可调的策略.

科学领域:

生物技术是生物技术.
材料科学材料科学材料科学
纳米医学是一种纳米医学.

背景情况:

非病毒载体对信使RNA (mRNA) 疗法有前途,但在系统管理后与器官选择性作斗争.
实现针对性地将mRNA输送到特定器官仍然是开发有效的mRNA疗法的一个重大障碍.
聚合物纳米粒子 (PNPs) 为控制药物输送提供了潜在的解决方案,但它们的器官向能力需要进一步优化.

研究的目的:

设计新的疏水聚合物纳米粒子 (PNPs) 以实现高效和器官选择性的mRNA输送.
合成和表征由合聚乙烯胺 (PEI) 衍生的新型疏水聚合物.
研究这些PNP的结构功能关系,用于mRNA治疗中的可调节器官向.

主要方法:

通过将2-phenylethyl acrylate (PA) 移植到PEI上,合成了9种新的疏水聚合物,其分子重量和食分子比率各不相同.
通过小鼠模型在体外和体内对mRNA传递效率和选择性进行了评估.
选择了基于体外转染查的最佳PNP候选人,用于进一步的全身传递研究.

主要成果:

在体内研究中确定了三个最佳PNP候选物 (6PP3-PNP,12PP6-PNP和24PP12-PNP).
值得注意的是,6PP3-PNP证明了偏好的mRNA输送到脏,与12PP6-PNP和24PP12-PNP的肝脏热流不同.
所有测试的PNP,特别是6PP3-PNP,在体外和体内都表现出极好的生物相容性.

结论:

该研究成功地设计了可调节的疏水PEI基PNP,用于器官选择性mRNA输送.
阐明了结构-功能关系,证明了聚合物修饰如何影响mRNA向.
这些发现扩大了mRNA疗法的潜力,特别是免疫疗法,通过提供针对性传递的策略.

关键词:

提供mRNA的交付.器官选择性的器官选择性聚乙烯胺聚乙烯胺聚合物纳米粒子的聚合物纳米粒子.脊髓脊髓脊髓是一个

更多相关视频

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...